Efficacy of umbilical cord mesenchymal stem cell transplantation in the treatment of cirrhosis patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-11001488

Enrollment

Unknown

Registered

2011-08-27

Start date

2011-09-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhosis

Interventions

A:umbilical cord mesenchymal stem cells transplantation

Eligibility

Sex/Gender

All

Age

35 Years to 63 Years

Inclusion criteria

Inclusion criteria: cirrhosis patients whose Child grade were <3

Exclusion criteria

Exclusion criteria: Severe cardiovascular disease or imunocompromised

Design outcomes

Primary

Measure	Time frame
biochemical markers of liver;	—

Secondary

Measure	Time frame
liver ultrasoun;	—

Countries

China

Contacts

Public ContactYihua An

riveran@163.com+86 10 57976849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026